BIOMARIN PHARMACEUTICAL INC
Reported by North Star Investment Management Corp
Reported 0 shares, down 2,000 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
|
This position's reported history falls outside the five-year preview window. A free account unlocks it.
Unlock full history
|
|||||||
Who else reported the position
50 managers reported BIOMARIN PHARMACEUTICAL INC for Q3 2018.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Bank of America Corporation | Added | 43,774,000 | +16,411,000 | < 0.01% | $45,073,000 | 15 qtrs |
| Allianz Asset Management GmbH | Unchanged | 39,535,000 | 0 | 0.04% | $40,970,000 | 14 qtrs |
| DEUTSCHE BANK AG | Added | 30,175,000 | +175,000 | 0.02% | $31,070,000 | 20 qtrs |
| Weiss Asset Management LP | Unchanged | 0 | 0 | 2.16% | $28,040,000 | 1 qtr |
| SUSQUEHANNA INTERNATIONAL GROUP LLP | Unchanged | 0 | 0 | < 0.01% | $25,988,000 | 2 qtrs |
| AQR Arbitrage LLC | New | 24,825,000 | +24,825,000 | 0.3% | $25,686,000 | 1 qtr |
| WELLS FARGO & COMPANY MN | Added | 21,425,000 | +19,142,000 | < 0.01% | $22,061,000 | 20 qtrs |
| CSS LLC IL | Added | 20,256,000 | +17,756,000 | 0.89% | $20,993,000 | 3 qtrs |
| CAPSTONE INVESTMENT ADVISORS LLC | Added | 17,000,000 | +7,000,000 | 0.2% | $17,589,000 | 2 qtrs |
| JPMorgan Chase & Co | Added | 15,702,000 | +9,067,000 | < 0.01% | $16,273,000 | 20 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2018
- Filed
- October 11, 2018
- Filing type
- 13F-HR
- Position type
- Convertible
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.